LivaNova Strengthens Board Leadership with Appointment of Jette Nygaard-Andersen LivaNova PLC, a global medical technology company focused on developing innovative therapies for patients with neurological and cardiovascular conditions, has announced the election of Jette Nygaard-Andersen to its Board of Directors…
Merck Animal Health to Acquire TARGAN, Expanding Poultry Technology and Biodevice Innovation Capabilities Merck Animal Health, known as MSD Animal Health outside the United States and Canada and operating as a division of Merck & Co., Inc., has announced the…
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors and Audit Committee Leadership Role Vir Biotechnology has announced the appointment of Timothy Coughlin to its Board of Directors, effective June 9, 2026. In addition to joining the board, Coughlin will…
Blue Matter Expands Healthcare Policy Support Capabilities for Life Sciences, Led by Partner Milena Sullivan Blue Matter has announced the launch of an expanded healthcare policy capability designed specifically to support biopharmaceutical clients navigating an increasingly complex regulatory and reimbursement…
Alesis LLC Expands Apnea Network with Three New Joint Ventures Across Chicago, Upper Michigan, and South Florida Within a Week Alesis LLC has announced a rapid expansion of its Alesis Apnea Network, adding three new joint venture clinic locations within…
Corsair Pharma to Present Three Phase 1 Clinical Data Readouts for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference Corsair Pharma, Inc., a privately held biopharmaceutical company focused on innovative drug delivery systems for cardiopulmonary diseases, has announced…
Vizgen® to Advance Cell Atlas Research with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting Vizgen, Inc., a spatial multiomics company and developer of the MERSCOPE Ultra™ platform, has announced a major expansion of its spatial…
OrsoBio to Present Preclinical and Clinical Data from Its Mitochondrial Protonophore Portfolio at ADA 2026 Scientific Sessions OrsoBio, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for obesity and related metabolic disorders, has announced a series of new…
Gilead Highlights Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa Gilead Sciences has commended the leadership of the Government of South Africa and the Global Fund for their efforts to accelerate access to lenacapavir, a long-acting HIV…
HSS Surgeon Riley J. Williams III Appointed Venue Medical Officer for FIFA World Cup 26™ in New York–New Jersey Region FIFA World Cup 26™ has announced the appointment of Hospital for Special Surgery (HSS) Sports Medicine Surgeon Riley J. Williams…
Fujifilm Strengthens Life Sciences Leadership Across Biomanufacturing and iPSC Businesses FUJIFILM Holdings America Corporation has announced expanded leadership responsibilities for three senior executives across its Life Sciences Group, reinforcing the company’s strategic focus on cell therapy, biologics manufacturing, and induced…
New Evidence Supports Ketogenic Therapy as a Potential Treatment for Anorexia Nervosa A pilot clinical study published in Communications Medicine has reported promising early evidence that a ketogenic nutritional intervention may be both safe and potentially beneficial for individuals with…